Do cerebral microbleeds affect cognition in patients with symptomatic small vessel disease?

Table 2 Antiplatelet intake differences between CMB-positive and CMB-negative groups

Medications		CMB-positive group	CMB-negative group	Χ²	P value
Medications		(%) No	(%) No	Χ²	P value
On antiplatelets	No	(40%) 16	(66.7%) 30	6.06	0.01
On antiplatelets	Yes	(60%) 24	(33.3%) 15	6.06	0.01

Data are expressed as frequency and percentage; P value < 0.05 significant; Χ² Chi square test